Researchers at the University of North Carolina at Chapel Hill have found that preschoolers with Autism Spectrum Disorder (ASD) who receive high-quality early intervention benefit developmentally regardless of the treatment ...
Jul 16, 2013
0
0
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical Center. The findings ...
Jun 12, 2013
0
0
(Medical Xpress)—An investigational drug that targets the immune system's ability to fight cancer is showing promising results in Yale Cancer Center (YCC) patients with a variety of advanced or metastatic forms of the disease. ...
Jun 4, 2013
0
0
The ability to combine all of a patient's neurological test results into one detailed, interactive "brain map" could help doctors diagnose and tailor treatment for a range of neurological disorders, from autism to epilepsy. ...
Jun 3, 2013
0
0
Men's upper-body strength predicts their political opinions on economic redistribution, according to new research published in Psychological Science, a journal of the Association for Psychological Science.
May 15, 2013
0
0
A target article recently published in Journal of Applied Research in Memory and Cognition (JARMAC) reviews various high-profile false convictions. It provides an overview of classic psychological research on expectancy and ...
Apr 22, 2013
0
0
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have developed a promising new antibiotic to treat potentially deadly gastrointestinal infections without harming the beneficial probiotic bacteria ...
Apr 12, 2013
0
0
Collaborative research presented by the University of Colorado Cancer Center, the University of North Carolina at Chapel Hill, Harvard Medical School and the University of Pittsburgh, at the American Association for Cancer ...
Apr 9, 2013
0
0
Breast cancers that lack estrogen receptors are more difficult to treat than ER+ cancers. Research presented at the AACR Annual Meeting 2013 demonstrates an investigational drug, Paragazole, that makes triple-negative breast ...
Apr 8, 2013
0
0
The investigational drug AZD5363, which has shown activity in preclinical studies, was well tolerated in humans, and two patients with advanced solid tumors showed partial response, according to data presented at the AACR ...
Apr 8, 2013
0
0
